Researchers at UC Irvine issue a warning that GLP-1RAs may be dangerous for children Source: UC Irvine School of Medicine Irvine, CA, August 28, 2023 A team of clinicians, exercise scientists, pharmaceutical scholars, ethicists and behavioral experts at the University of California, Irvine, outlined their concerns that the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) to treat childhood obesity and type 2 diabetes may have unintended and adverse consequences for childrens health
Both BPC-157 and KPV have been studied for their positive effects on gut barrier function, reducing inflammation, and supporting overall gastrointestinal health
Nausea and stomach changes are common, and providers usually start low and increase the dose slowly to make that easier
In research settings, tesamorelin is studied for its interaction with GHRH receptors, where it plays a role in signaling pathways associated with growth-hormone release, metabolic regulation, and endocrine communication
This downstream effect can delay or lighten menstrual periods
Balen A